Literature DB >> 11530310

Incident pregnancy rates in HIV infected and HIV uninfected at-risk adolescents.

L Levin1, L Henry-Reid, D A Murphy, L Peralta, M Sarr, Y Ma, A S Rogers.   

Abstract

PURPOSE: To compare pregnancy incidence between HIV infected and HIV uninfected adolescents over a 3-year period and to characterize factors that differentiate pregnant from nonpregnant HIV infected females.
METHODS: Female adolescents enrolled in Reaching for Excellence in Adolescent Care and Health (REACH), a national cohort study, and nonpregnant at baseline comprised the sample (n = 345). Subject information on pregnancy, risk behavior, and psychosocial characteristics was obtained through interview, chart review, physical examination and laboratory data collected every 3 months. Incident pregnancy rate was analyzed using Cox proportional hazards modeling; the predictors of incident pregnancy were evaluated using repeated measures analysis.
RESULTS: Ninety-four pregnancies were identified over 3 years. No significant difference in pregnancy incidence was detected between HIV infected and uninfected females (20.6 and 28.4 per 100 person-years, respectively, p = .16). However, for adolescents with living children at entry, HIV infected females were significantly less likely to become pregnant than HIV uninfected (HR = .45; p = .03). Among HIV infected adolescents, significant predictors of incident pregnancy were older age (p = .01) and not using hormonal contraception (p = .00), whereas increased spiritual hope and passive problem-solving capacity were protective against pregnancy (p = .02, and.05, respectively). Multivariate analysis revealed pregnancy prior to study entry to be predictive for (OR = 3.0; 95% CI: 1.2-7.7), and increased spiritual hope to be protective (OR = .4; 95% CI: .2-.9) against incident pregnancy in HIV infected females without the hormonal contraceptive variable in the model.
CONCLUSIONS: The pregnancy rate is high in this study population. Further research is needed into its determinants and attenuating factors, particularly the role of spiritual elements, to design better contraceptive services and reproduction-related education targeting high-risk youth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530310     DOI: 10.1016/s1054-139x(01)00281-6

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  6 in total

Review 1.  Parenting Among Adolescents and Young Adults with Human Immunodeficiency Virus Infection in the United States: Challenges, Unmet Needs, and Opportunities.

Authors:  Kendra Hatfield-Timajchy; Jennifer L Brown; Lisa B Haddad; Rana Chakraborty; Athena P Kourtis
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

Review 2.  The reproductive health behaviors of HIV-infected young women in the United States: A literature review.

Authors:  Marion W Carter; Joan M Kraft; Kendra Hatfield-Timajchy; Margaret C Snead; Larisa Ozeryansky; Amy M Fasula; Linda J Koenig; Athena P Kourtis
Journal:  AIDS Patient Care STDS       Date:  2013-12       Impact factor: 5.078

3.  Longing: the lived experience of spirituality in adolescents with Duchenne muscular dystrophy.

Authors:  Shelley-Rae Pehler; Martha Craft-Rosenberg
Journal:  J Pediatr Nurs       Date:  2009-05-26       Impact factor: 2.145

4.  Gender Power Inequality and Continued Sexual Risk Behavior among Racial/Ethnic Minority Adolescent and Young Adult Women Living with HIV.

Authors:  Nancy Van Devanter; Alexandra Duncan; Jeffrey Birnbaum; Tiphani Burrell-Piggott; Karolynn Siegel
Journal:  J AIDS Clin Res       Date:  2011-11-25

5.  Repeat pregnancies among HIV-infected women enrolled in clinical trial PACTG1022.

Authors:  D Heather Watts; Sharon Huang; Susan E Cohn; Laura Smith; Jane Hitti
Journal:  J Acquir Immune Defic Syndr       Date:  2009-06-01       Impact factor: 3.731

6.  Contraception in HIV-positive female adolescents.

Authors:  Nadia T Kancheva Landolt; Sudrak Lakhonphon; Jintanat Ananworanich
Journal:  AIDS Res Ther       Date:  2011-06-01       Impact factor: 2.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.